Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PHASE 1, RANDOMIZED, CROSSOVER DESIGN STUDY TO ASSESS PALATABILITY OF OSIVELOTOR (PF-07940367) PEDIATRIC FORMULATIONS WITH DOSING VEHICLE (PART 1) AND RANDOMIZED, SINGLE-DOSE, PARALLEL DESIGN STUDY TO ESTIMATE RELATIVE BIOAVAILABILITY OF OSIVELOTOR PEDIATRIC FORMULATION WITH DOSING VEHICLE AND WITH WATER COMPARED TO CLINICAL TABLET FORMULATION, AND EFFECT OF FOOD AND/OR ACID-REDUCING AGENT ON BIOAVAILABILITY IN HEALTHY ADULT PARTICIPANTS (PART 2)

NCT06507904 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06507904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06507904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PHASE 1, RANDOMIZED, CROSSOVER DESIGN STUDY TO ASSESS PALATABILITY OF OSIVELOTOR (PF-07940367) PEDIATRIC FORMULATIONS WITH DOSING VEHICLE (PART 1) AND RANDOMIZED, SINGLE-DOSE, PARALLEL DESIGN STUDY TO ESTIMATE RELATIVE BIOAVAILABILITY OF OSIVELOTOR PEDIATRIC FORMULATION WITH DOSING VEHICLE AND WITH WATER COMPARED TO CLINICAL TABLET FORMULATION, AND EFFECT OF FOOD AND/OR ACID-REDUCING AGENT ON BIOAVAILABILITY IN HEALTHY ADULT PARTICIPANTS (PART 2)
Lead sponsor
Pfizer
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 22, 2026
Completion date
May 10, 2027
Enrollment
52 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy